{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:51:10Z","timestamp":1783997470710,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T00:00:00Z","timestamp":1602460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although doxorubicin (Dox) is an effective antitumor antibiotic in the anthracycline class, it often induces the undesirable side effect of cardiomyopathy leading to congestive heart failure, which limits its clinical use. The primary goal of this study is to evaluate a reliable translational method for Dox-induced cardiotoxicity (CTX) screening, aiming to identify a high-risk population and to discover new strategies to predict and investigate this phenomenon. Early identification of the presence of iron deposits and genetic and environmental triggers that predispose individuals to increased risk of Dox-induced CTX (e.g., overexpression of Toll-like receptor 4 (TLR4)) will enable the early implementation of countermeasure therapy, which will improve the patient\u2019s chance of survival. Our cohort consisted of 25 consecutive patients with pathologically confirmed cancer undergoing Dox chemotherapy and 12 control patients. The following parameters were measured: serum TLR4 (baseline), serum transferrin (baseline and 6-week follow-up) and iron deposition (baseline and 6-week follow-up). The average number of gene expression units was 0.121 for TLR4 (range 0.051\u20130.801). We subsequently correlated serum TLR4 levels in our cohort with myocardial iron overload using the cardiac magnetic resonance (CMR) T2* technique, the ventricular function (% ejection fraction, %EF) and serum transferrin levels. There is a strong negative linear relationship between serum TLR4 and CMR T2* values (r\u2009=\u2009\u2009\u2212\u20090.9106, ****<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). There is also a linear correlation (either positive or negative) with EF and transferrin; no established relationship related to the sex of the patients was found. Patients with elevated serum TLR4 at baseline also exhibited an increase in serum transferrin levels and Dox-induced left ventricular dysfunction with a decreased EF (&lt;\u200950%); this phenomenon was observed in 7 of 25 patients (28%) at the 6-week follow-up. There were no significant differences or correlations based on sex. We concluded that there is a direct relationship between Dox-induced CTX (indicated by elevated serum TLR4) and the times (ms) for T2* (decreases in which correspond to immediate and rapid iron overload).<\/jats:p>","DOI":"10.1038\/s41598-020-73946-9","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T10:02:42Z","timestamp":1602496962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Toll-like receptor 4 (TLR4) expression is correlated with T2* iron deposition in response to doxorubicin treatment: cardiotoxicity risk assessment"],"prefix":"10.1038","volume":"10","author":[{"given":"Nelu-Mihai","family":"Trofenciuc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora Diana","family":"Bordejevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirela Cleopatra","family":"Tomescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucian","family":"Petrescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simina","family":"Crisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliviana","family":"Geavlete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Mischie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru Fica Mircea","family":"Onel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alciona","family":"Sasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina Ligia","family":"Pop-Moldovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"73946_CR1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.cardfail.2016.04.008","volume":"22","author":"V Mercurio","year":"2016","unstructured":"Mercurio, V. et al. Models of heart failure based on the cardiotoxicity of anticancer drugs. J. Cardiac. Fail. 22, 449\u2013458 (2016).","journal-title":"J. Cardiac. Fail."},{"key":"73946_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/cgt.2013.77","volume":"21","author":"CR Balistreri","year":"2014","unstructured":"Balistreri, C. R., Candore, G., Lio, D. & Carruba, G. Prostate cancer: From the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatments. Cancer Gene Ther. 21, 2\u201311 (2014).","journal-title":"Cancer Gene Ther."},{"key":"73946_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/10408363.2016.1261270","volume":"54","author":"L Cao","year":"2017","unstructured":"Cao, L., Zhu, W., Wagar, E. A. & Meng, Q. H. Biomarkers for monitoring chemotherapy-induced cardiotoxicity. Crit. Rev. Clin. Lab. Sci. 54, 87\u2013101 (2017).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"73946_CR4","doi-asserted-by":"publisher","first-page":"651","DOI":"10.2147\/CIA.S161385","volume":"13","author":"S Cri\u015fan","year":"2018","unstructured":"Cri\u015fan, S. et al. Reduced ejection fraction heart failure - New data from multicenter studies and national registries regarding general and elderly populations: hopes and disappointments. Clin. Interv. Aging 13, 651\u2013656 (2018).","journal-title":"Clin. Interv. Aging"},{"key":"73946_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni1050","volume":"5","author":"EK Brint","year":"2004","unstructured":"Brint, E. K. et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol. 5, 373\u2013379 (2004).","journal-title":"Nat. Immunol."},{"key":"73946_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/cgt.2017.4","volume":"24","author":"AL Pop-Moldovan","year":"2017","unstructured":"Pop-Moldovan, A. L. et al. Customized laboratory TLR4 and TLR2 detection method from peripheral human blood for early detection of doxorubicin-induced cardiotoxicity. Cancer Gene Ther. 24, 203\u2013207 (2017).","journal-title":"Cancer Gene Ther."},{"key":"73946_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/cgt.2017.2","volume":"24","author":"T Moriyama","year":"2017","unstructured":"Moriyama, T., Suzuki, T., Chang, M. O., Kitajima, M. & Takaku, H. Baculovirus directly activates murine NK cells via TLR9. Cancer Gene Ther. 24, 175\u2013179 (2017).","journal-title":"Cancer Gene Ther."},{"key":"73946_CR8","first-page":"1","volume":"7","author":"Y Ma","year":"2012","unstructured":"Ma, Y. et al. Toll-like receptor (tlr) 2 and tlr4 differentially regulate doxorubicin induced cardiomyopathy in mice. PLoS ONE 7, 1\u201310 (2012).","journal-title":"PLoS ONE"},{"key":"73946_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1536\/ihj.17-084","volume":"59","author":"P Zhang","year":"2018","unstructured":"Zhang, P., Shao, L. & Ma, J. Toll-like receptors 2 and 4 predict new-onset atrial fibrillation in acute myocardial infarction patients. Int. Heart J. 59, 64\u201370 (2018).","journal-title":"Int. Heart J."},{"key":"73946_CR10","doi-asserted-by":"publisher","unstructured":"Kuvibidila, S. R., Baliga, S. B., Chandra, L. C. & French, C. L. The role of iron in immunity and inflammation: Implications for the response to infection. Diet, Immunity and Inflammation (Woodhead Publishing Limited, 2013). doi:https:\/\/doi.org\/10.1533\/9780857095749.2.193.","DOI":"10.1533\/9780857095749.2.193"},{"key":"73946_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/apha.13324","volume":"228","author":"D Vela","year":"2020","unstructured":"Vela, D. Keeping heart homeostasis in check through the balance of iron metabolism. Acta Physiol. 228, 1\u201318 (2020).","journal-title":"Acta Physiol."},{"key":"73946_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00277-011-1164-9","volume":"90","author":"M Delforge","year":"2011","unstructured":"Delforge, M. et al. Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes. Ann. Hematol. 90, 655\u2013666 (2011).","journal-title":"Ann. Hematol."},{"key":"73946_CR13","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/cr.2016.95","volume":"26","author":"M Gao","year":"2016","unstructured":"Gao, M. et al. Ferroptosis is an autophagic cell death process. Cell Res. 26, 1021\u20131032 (2016).","journal-title":"Cell Res."},{"key":"73946_CR14","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"73946_CR15","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/brain\/awz072","volume":"142","author":"G Costain","year":"2019","unstructured":"Costain, G. et al. Absence of iron-responsive element-binding protein 2 causes a novel neurodegenerative syndrome. Brain 142, 1195\u20131202 (2019).","journal-title":"Brain"},{"key":"73946_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep13502","volume":"5","author":"I Zi\u00f3\u0142kowska-Suchanek","year":"2015","unstructured":"Zi\u00f3\u0142kowska-Suchanek, I. et al. Susceptibility loci in lung cancer and COPD: association of IREB2 and FAM13A with pulmonary diseases. Sci. Rep. 5, 1\u201314 (2015).","journal-title":"Sci. Rep."},{"key":"73946_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/84859","volume":"27","author":"T LaVaute","year":"2001","unstructured":"LaVaute, T. et al. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27, 209\u2013214 (2001).","journal-title":"Nat. Genet."},{"key":"73946_CR18","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1152\/ajpheart.00328.2007","volume":"293","author":"S Turakhia","year":"2007","unstructured":"Turakhia, S. et al. Doxorubicin-induced cardiotoxicity: Direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27. Am. J. Physiol. Heart Circ. Physiol. 293, 3111\u20133121 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"73946_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","volume":"56","author":"G Minotti","year":"2004","unstructured":"Minotti, G., Menna, P., Salvatorelli, E., Cairo, G. & Gianni, L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56, 185\u2013229 (2004).","journal-title":"Pharmacol. Rev."},{"key":"73946_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R. et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171, 273\u2013285 (2017).","journal-title":"Cell"},{"key":"73946_CR21","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1152\/physrev.00041.2016","volume":"98","author":"M Sarhan","year":"2018","unstructured":"Sarhan, M., Land, W. G., Tonnus, W., Hugo, C. P. & Linkermann, A. Origin and consequences of necroinflammation. Physiol. Rev. 98, 727\u2013780 (2018).","journal-title":"Physiol. Rev."},{"key":"73946_CR22","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1172\/JCI126428","volume":"129","author":"W Li","year":"2019","unstructured":"Li, W. et al. Ferroptotic cell death and TLR4\/Trif signaling initiate neutrophil recruitment after heart transplantation. J. Clin. Invest. 129, 2293\u20132304 (2019).","journal-title":"J. Clin. Invest."},{"key":"73946_CR23","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1200\/JCO.2004.06.033","volume":"22","author":"O Hequet","year":"2004","unstructured":"Hequet, O. et al. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults. J. Clin. Oncol. 22, 1864\u20131871 (2004).","journal-title":"J. Clin. Oncol."},{"key":"73946_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/RTI.0000000000000430","volume":"35","author":"CP Houbois","year":"2020","unstructured":"Houbois, C. P., Thavendiranathan, P. & Wintersperger, B. J. Cardiovascular magnetic resonance imaging: identifying the effects of cancer therapy. J. Thorac. Imaging 35, 12\u201325 (2020).","journal-title":"J. Thorac. Imaging"},{"key":"73946_CR25","first-page":"2","volume":"101","author":"MHH dos Santos","year":"2013","unstructured":"dos Santos, M. H. H. Detection of subclinical trastuzumab-induced cardiotoxicity in patients with breast cancer. Arq. Bras. Cardiol. 101, 2\u20133 (2013).","journal-title":"Arq. Bras. Cardiol."},{"key":"73946_CR26","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.jacc.2010.11.063","volume":"57","author":"N Fallah-Rad","year":"2011","unstructured":"Fallah-Rad, N. et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor iipositive breast cancer treated with ad. J. Am. Coll. Cardiol. 57, 2263\u20132270 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"73946_CR27","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/cgt.2009.53","volume":"16","author":"DD Rao","year":"2009","unstructured":"Rao, D. D., Senzer, N., Cleary, M. A. & Nemunaitis, J. Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development. Cancer Gene Ther. 16, 807\u2013809 (2009).","journal-title":"Cancer Gene Ther."},{"key":"73946_CR28","doi-asserted-by":"crossref","unstructured":"Reeder, S. B., Faranesh, A. Z., Boxerman, J. L. & Mcveigh, E. R. In Vivo Measurement of T2* and Field Inhomogeneity Maps in the Human Heart at 1 . 5 T 8 echoes 16 echoes 32 echoes 64 echoes Base Mid Apex. Mrm3, (1998).","DOI":"10.1002\/mrm.1910390617"},{"key":"73946_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/824135","volume":"1","author":"K Komamura","year":"2013","unstructured":"Komamura, K. Similarities and differences between the pathogenesis and pathophysiology of diastolic and systolic heart failure. Cardiol. Res. Pract. 1, 1\u201310 (2013).","journal-title":"Cardiol. Res. Pract."},{"key":"73946_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"DR Messroghli","year":"2017","unstructured":"Messroghli, D. R. et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imagi. J. Cardiovasc. Magn. Reson. 19, 75 (2017).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"73946_CR31","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1021\/jm401006s","volume":"57","author":"F Peri","year":"2014","unstructured":"Peri, F. & Calabrese, V. Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update. J. Med. Chem. 57, 3612\u20133622 (2014).","journal-title":"J. Med. Chem."},{"key":"73946_CR32","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1158\/0008-5472.CAN-15-3034","volume":"76","author":"L Wang","year":"2016","unstructured":"Wang, L. et al. Doxorubicin-induced systemic inflammation is driven by upregulation of toll-like receptor TLR4 and endotoxin leakage. Cancer Res. 76, 6631\u20136642 (2016).","journal-title":"Cancer Res."},{"key":"73946_CR33","doi-asserted-by":"crossref","unstructured":"Meyer-Hamme, G. et al. A survey of chinese medicinal herbal treatment for chemotherapy-induced oral mucositis. Evidence-based Complement. Altern. Med.2013, (2013).","DOI":"10.1155\/2013\/284959"},{"key":"73946_CR34","first-page":"188","volume":"8","author":"JC Lori","year":"2010","unstructured":"Lori, J. C., Stein, T. J. & Thamm, D. H. Doxorubicin and cyclophosphamide for the treatment of canine lymphoma: a randomized, placebo-controlled study. Vet. Comp. Oncol. 8, 188\u2013195 (2010).","journal-title":"Vet. Comp. Oncol."},{"key":"73946_CR35","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1111\/jcmm.12659","volume":"19","author":"L Liu","year":"2015","unstructured":"Liu, L. et al. Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction. J. Cell. Mol. Med. 19, 2728\u20132740 (2015).","journal-title":"J. Cell. Mol. Med."},{"key":"73946_CR36","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cardfail.2016.03.012","volume":"22","author":"DJ Lenihan","year":"2016","unstructured":"Lenihan, D. J. et al. Cardio-oncology training: a proposal from the international cardioncology society and Canadian cardiac oncology network for a new multidisciplinary specialty. J. Card. Fail. 22, 465\u2013471 (2016).","journal-title":"J. Card. Fail."},{"key":"73946_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/1354750X.2015.1040839","volume":"20","author":"W Van Boxtel","year":"2015","unstructured":"Van Boxtel, W. et al. New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide. Biomarkers 20, 143\u2013148 (2015).","journal-title":"Biomarkers"},{"key":"73946_CR38","first-page":"7209","volume":"173","author":"DC Palmer","year":"2008","unstructured":"Palmer, D. C. et al. Comprehensive variation discovery in single human genomes. Nat. Genet. 173, 7209\u20137216 (2008).","journal-title":"Nat. Genet."},{"key":"73946_CR39","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","volume":"22","author":"LJ Anderson","year":"2001","unstructured":"Anderson, L. J. et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur. Heart J. 22, 2171\u20132179 (2001).","journal-title":"Eur. Heart J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73946-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73946-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73946-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:57:31Z","timestamp":1670360251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-73946-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["73946"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-73946-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]},"assertion":[{"value":"19 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17013"}}